Report cover image

Global Heparin Market Analysis and Forecast 2024-2030

Publisher APO Research, Inc.
Published Apr 27, 2024
Length 218 Pages
SKU # APRC18962899

Description

Global Heparin Market Analysis and Forecast 2024-2030


Summary

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

According to APO Research, The global Heparin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Heparin include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioibérica and Dongcheng Biochemicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Heparin production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Heparin by region (region level and country level), by Company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

This report presents an overview of global market for Heparin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Heparin, also provides the consumption of main regions and countries. Of the upcoming market potential for Heparin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Heparin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Heparin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Heparin sales, projected growth trends, production technology, application and end-user industry.

Heparin segment by Company

Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio
Heparin segment by Type

Heparin Sodium Raw Material Drug
Heparin Calcium Raw Material Drug
Heparin segment by Application

Low Molecular Weight Heparin Preparation
Standard Heparin Preparation
Heparin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Heparin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Heparin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heparin sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: Middle East, Africa, Latin America by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.

Table of Contents

218 Pages
1 Market Overview
1.1 Product Definition
1.2 Heparin Market by Type
1.2.1 Global Heparin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Heparin Sodium Raw Material Drug
1.2.3 Heparin Calcium Raw Material Drug
1.3 Heparin Market by Application
1.3.1 Global Heparin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Low Molecular Weight Heparin Preparation
1.3.3 Standard Heparin Preparation
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Heparin Market Dynamics
2.1 Heparin Industry Trends
2.2 Heparin Industry Drivers
2.3 Heparin Industry Opportunities and Challenges
2.4 Heparin Industry Restraints
3 Global Heparin Production Overview
3.1 Global Heparin Production Capacity (2019-2030)
3.2 Global Heparin Production by Region: 2019 VS 2023 VS 2030
3.3 Global Heparin Production by Region
3.3.1 Global Heparin Production by Region (2019-2024)
3.3.2 Global Heparin Production by Region (2025-2030)
3.3.3 Global Heparin Production Market Share by Region (2019-2030)
3.4 North America
3.5 Europe
3.6 China
3.7 Mexico
4 Global Market Growth Prospects
4.1 Global Heparin Revenue Estimates and Forecasts (2019-2030)
4.2 Global Heparin Revenue by Region
4.2.1 Global Heparin Revenue by Region: 2019 VS 2023 VS 2030
4.2.2 Global Heparin Revenue by Region (2019-2024)
4.2.3 Global Heparin Revenue by Region (2025-2030)
4.2.4 Global Heparin Revenue Market Share by Region (2019-2030)
4.3 Global Heparin Sales Estimates and Forecasts 2019-2030
4.4 Global Heparin Sales by Region
4.4.1 Global Heparin Sales by Region: 2019 VS 2023 VS 2030
4.4.2 Global Heparin Sales by Region (2019-2024)
4.4.3 Global Heparin Sales by Region (2025-2030)
4.4.4 Global Heparin Sales Market Share by Region (2019-2030)
4.5 US & Canada
4.6 Europe
4.7 China
4.8 Asia (Excluding China)
4.9 Middle East, Africa and Latin America
5 Market Competitive Landscape by Manufacturers
5.1 Global Heparin Revenue by Manufacturers
5.1.1 Global Heparin Revenue by Manufacturers (2019-2024)
5.1.2 Global Heparin Revenue Market Share by Manufacturers (2019-2024)
5.1.3 Global Heparin Manufacturers Revenue Share Top 10 and Top 5 in 2023
5.2 Global Heparin Sales by Manufacturers
5.2.1 Global Heparin Sales by Manufacturers (2019-2024)
5.2.2 Global Heparin Sales Market Share by Manufacturers (2019-2024)
5.2.3 Global Heparin Manufacturers Sales Share Top 10 and Top 5 in 2023
5.3 Global Heparin Sales Price by Manufacturers (2019-2024)
5.4 Global Heparin Key Manufacturers Ranking, 2022 VS 2023 VS 2024
5.5 Global Heparin Key Manufacturers Manufacturing Sites & Headquarters
5.6 Global Heparin Manufacturers, Product Type & Application
5.7 Global Heparin Manufacturers Commercialization Time
5.8 Market Competitive Analysis
5.8.1 Global Heparin Market CR5 and HHI
5.8.2 2023 Heparin Tier 1, Tier 2, and Tier 3
6 Heparin Market by Type
6.1 Global Heparin Revenue by Type
6.1.1 Global Heparin Revenue by Type (2019 VS 2023 VS 2030)
6.1.2 Global Heparin Revenue by Type (2019-2030) & (US$ Million)
6.1.3 Global Heparin Revenue Market Share by Type (2019-2030)
6.2 Global Heparin Sales by Type
6.2.1 Global Heparin Sales by Type (2019 VS 2023 VS 2030)
6.2.2 Global Heparin Sales by Type (2019-2030) & (B Units)
6.2.3 Global Heparin Sales Market Share by Type (2019-2030)
6.3 Global Heparin Price by Type
7 Heparin Market by Application
7.1 Global Heparin Revenue by Application
7.1.1 Global Heparin Revenue by Application (2019 VS 2023 VS 2030)
7.1.2 Global Heparin Revenue by Application (2019-2030) & (US$ Million)
7.1.3 Global Heparin Revenue Market Share by Application (2019-2030)
7.2 Global Heparin Sales by Application
7.2.1 Global Heparin Sales by Application (2019 VS 2023 VS 2030)
7.2.2 Global Heparin Sales by Application (2019-2030) & (B Units)
7.2.3 Global Heparin Sales Market Share by Application (2019-2030)
7.3 Global Heparin Price by Application
8 Company Profiles
8.1 Hepalink
8.1.1 Hepalink Comapny Information
8.1.2 Hepalink Business Overview
8.1.3 Hepalink Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Hepalink Heparin Product Portfolio
8.1.5 Hepalink Recent Developments
8.2 Changshan Pharm
8.2.1 Changshan Pharm Comapny Information
8.2.2 Changshan Pharm Business Overview
8.2.3 Changshan Pharm Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Changshan Pharm Heparin Product Portfolio
8.2.5 Changshan Pharm Recent Developments
8.3 Qianhong Bio-pharma
8.3.1 Qianhong Bio-pharma Comapny Information
8.3.2 Qianhong Bio-pharma Business Overview
8.3.3 Qianhong Bio-pharma Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Qianhong Bio-pharma Heparin Product Portfolio
8.3.5 Qianhong Bio-pharma Recent Developments
8.4 Opocrin
8.4.1 Opocrin Comapny Information
8.4.2 Opocrin Business Overview
8.4.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Opocrin Heparin Product Portfolio
8.4.5 Opocrin Recent Developments
8.5 Pfizer
8.5.1 Pfizer Comapny Information
8.5.2 Pfizer Business Overview
8.5.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Pfizer Heparin Product Portfolio
8.5.5 Pfizer Recent Developments
8.6 Aspen Oss
8.6.1 Aspen Oss Comapny Information
8.6.2 Aspen Oss Business Overview
8.6.3 Aspen Oss Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Aspen Oss Heparin Product Portfolio
8.6.5 Aspen Oss Recent Developments
8.7 King-friend Biochemical Pharmaceutical
8.7.1 King-friend Biochemical Pharmaceutical Comapny Information
8.7.2 King-friend Biochemical Pharmaceutical Business Overview
8.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.7.4 King-friend Biochemical Pharmaceutical Heparin Product Portfolio
8.7.5 King-friend Biochemical Pharmaceutical Recent Developments
8.8 Bioibérica
8.8.1 Bioibérica Comapny Information
8.8.2 Bioibérica Business Overview
8.8.3 Bioibérica Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Bioibérica Heparin Product Portfolio
8.8.5 Bioibérica Recent Developments
8.9 Dongcheng Biochemicals
8.9.1 Dongcheng Biochemicals Comapny Information
8.9.2 Dongcheng Biochemicals Business Overview
8.9.3 Dongcheng Biochemicals Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Dongcheng Biochemicals Heparin Product Portfolio
8.9.5 Dongcheng Biochemicals Recent Developments
8.10 Jiulong Biochemicals
8.10.1 Jiulong Biochemicals Comapny Information
8.10.2 Jiulong Biochemicals Business Overview
8.10.3 Jiulong Biochemicals Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Jiulong Biochemicals Heparin Product Portfolio
8.10.5 Jiulong Biochemicals Recent Developments
8.11 Tiandong
8.11.1 Tiandong Comapny Information
8.11.2 Tiandong Business Overview
8.11.3 Tiandong Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.11.4 Tiandong Heparin Product Portfolio
8.11.5 Tiandong Recent Developments
8.12 Xinbai
8.12.1 Xinbai Comapny Information
8.12.2 Xinbai Business Overview
8.12.3 Xinbai Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.12.4 Xinbai Heparin Product Portfolio
8.12.5 Xinbai Recent Developments
8.13 Yino Pharma
8.13.1 Yino Pharma Comapny Information
8.13.2 Yino Pharma Business Overview
8.13.3 Yino Pharma Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.13.4 Yino Pharma Heparin Product Portfolio
8.13.5 Yino Pharma Recent Developments
8.14 Deebio
8.14.1 Deebio Comapny Information
8.14.2 Deebio Business Overview
8.14.3 Deebio Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.14.4 Deebio Heparin Product Portfolio
8.14.5 Deebio Recent Developments
9 North America
9.1 North America Heparin Market Size by Type
9.1.1 North America Heparin Revenue by Type (2019-2030)
9.1.2 North America Heparin Sales by Type (2019-2030)
9.1.3 North America Heparin Price by Type (2019-2030)
9.2 North America Heparin Market Size by Application
9.2.1 North America Heparin Revenue by Application (2019-2030)
9.2.2 North America Heparin Sales by Application (2019-2030)
9.2.3 North America Heparin Price by Application (2019-2030)
9.3 North America Heparin Market Size by Country
9.3.1 North America Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 North America Heparin Sales by Country (2019 VS 2023 VS 2030)
9.3.3 North America Heparin Price by Country (2019-2030)
9.3.4 U.S.
9.3.5 Canada
10 Europe
10.1 Europe Heparin Market Size by Type
10.1.1 Europe Heparin Revenue by Type (2019-2030)
10.1.2 Europe Heparin Sales by Type (2019-2030)
10.1.3 Europe Heparin Price by Type (2019-2030)
10.2 Europe Heparin Market Size by Application
10.2.1 Europe Heparin Revenue by Application (2019-2030)
10.2.2 Europe Heparin Sales by Application (2019-2030)
10.2.3 Europe Heparin Price by Application (2019-2030)
10.3 Europe Heparin Market Size by Country
10.3.1 Europe Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
10.3.2 Europe Heparin Sales by Country (2019 VS 2023 VS 2030)
10.3.3 Europe Heparin Price by Country (2019-2030)
10.3.4 Germany
10.3.5 France
10.3.6 U.K.
10.3.7 Italy
10.3.8 Russia
11 China
11.1 China Heparin Market Size by Type
11.1.1 China Heparin Revenue by Type (2019-2030)
11.1.2 China Heparin Sales by Type (2019-2030)
11.1.3 China Heparin Price by Type (2019-2030)
11.2 China Heparin Market Size by Application
11.2.1 China Heparin Revenue by Application (2019-2030)
11.2.2 China Heparin Sales by Application (2019-2030)
11.2.3 China Heparin Price by Application (2019-2030)
12 Asia (Excluding China)
12.1 Asia Heparin Market Size by Type
12.1.1 Asia Heparin Revenue by Type (2019-2030)
12.1.2 Asia Heparin Sales by Type (2019-2030)
12.1.3 Asia Heparin Price by Type (2019-2030)
12.2 Asia Heparin Market Size by Application
12.2.1 Asia Heparin Revenue by Application (2019-2030)
12.2.2 Asia Heparin Sales by Application (2019-2030)
12.2.3 Asia Heparin Price by Application (2019-2030)
12.3 Asia Heparin Market Size by Country
12.3.1 Asia Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 Asia Heparin Sales by Country (2019 VS 2023 VS 2030)
12.3.3 Asia Heparin Price by Country (2019-2030)
12.3.4 Japan
12.3.5 South Korea
12.3.6 India
12.3.7 Australia
12.3.8 China Taiwan
12.3.9 Southeast Asia
13 Middle East, Africa and Latin America
13.1 Middle East, Africa and Latin America Heparin Market Size by Type
13.1.1 Middle East, Africa and Latin America Heparin Revenue by Type (2019-2030)
13.1.2 Middle East, Africa and Latin America Heparin Sales by Type (2019-2030)
13.1.3 Middle East, Africa and Latin America Heparin Price by Type (2019-2030)
13.2 Middle East, Africa and Latin America Heparin Market Size by Application
13.2.1 Middle East, Africa and Latin America Heparin Revenue by Application (2019-2030)
13.2.2 Middle East, Africa and Latin America Heparin Sales by Application (2019-2030)
13.2.3 Middle East, Africa and Latin America Heparin Price by Application (2019-2030)
13.3 Middle East, Africa and Latin America Heparin Market Size by Country
13.3.1 Middle East, Africa and Latin America Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
13.3.2 Middle East, Africa and Latin America Heparin Sales by Country (2019 VS 2023 VS 2030)
13.3.3 Middle East, Africa and Latin America Heparin Price by Country (2019-2030)
13.3.4 Mexico
13.3.5 Brazil
13.3.6 Israel
13.3.7 Argentina
13.3.8 Colombia
13.3.9 Turkey
13.3.10 Saudi Arabia
13.3.11 UAE
14 Value Chain and Sales Channels Analysis
14.1 Heparin Value Chain Analysis
14.1.1 Heparin Key Raw Materials
14.1.2 Raw Materials Key Suppliers
14.1.3 Manufacturing Cost Structure
14.1.4 Heparin Production Mode & Process
14.2 Heparin Sales Channels Analysis
14.2.1 Direct Comparison with Distribution Share
14.2.2 Heparin Distributors
14.2.3 Heparin Customers
15 Concluding Insights
16 Appendix
16.1 Reasons for Doing This Study
16.2 Research Methodology
16.3 Research Process
16.4 Authors List of This Report
16.5 Data Source
16.5.1 Secondary Sources
16.5.2 Primary Sources
16.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.